Thursday, July 3, 2025 7/3/2025

Calming the Cytokine Storm: Unraveling the Biology of CRS and ICANS

Award Number: K08CA286762
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2029

Group Awards By:

View Award Description

Calming the Cytokine Storm: Unraveling the Biology of CRS and ICANS - PROJECT SUMMARY/ABSTRACT Chimeric antigen receptor T-cells (CART) have revolutionized cancer therapy. However, CART cause two common and severe toxicities: Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS). CRS and ICANS are overlapping phenomena that occur with a spectrum of severity from mild to life threatening. Effective therapies for CRS currently exist but severe refractory cases still occur. Effective therapies for ICANS are lacking. The pathophysiology of CRS and ICANS have not yet been fully defined, precluding development and translation of novel therapies. In particular, the role of the host innate immune system in these conditions is poorly understood. The specific objective of this project is to identify the cellular and cytokine initiators of CRS and the role of complement and the inflammasome in the biology of ICANS. In Specific Aim 1, the candidate will determine the number and transcriptional activation state of different monocyte and non-monocyte populations associated with CRS using single cell RNA sequencing (scRNAseq) and test the role of novel monocyte produced cytokines in the priming and initiation of CRS. In Specific Aim 2, the candidate will dissect the role of the inflammasome and complement dysregulation in the development of ICANS, and test individual and combined approaches for inflammasome and complement blockade in preventing and treating ICANS. The candidate is a pediatric oncologist committed to understanding immune dysregulation disorders that occur as a consequence of cancer immunotherapy. The proposed training plan and research project will be conducted at the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania (UPENN). CHOP and UPENN are leaders in cellular immunotherapies and basic and clinical immunology and will provide an outstanding environment in which to conduct the proposed research. Throughout the period of the award the candidate will be mentored by Dr. David Teachey and a very strong advisory committee including Drs. Ed Behrens, Marcela Maus, Wenchao Song and Stephan Grupp. The long-term goal of the candidate is to develop a research program devoted to understanding the role of the innate immune system in immune dysregulation related to cancer immunotherapies, and improving the health of patients by facilitating translation of less toxic, more effective immunotherapies. Completion of the proposed research project and the complementary training plan will provide a robust foundation to achieve this goal.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $248,509 )
2025	2025	THE CHILDREN'S HOSPITAL OF PHILADELPHIA	3401 CIVIC CENTER BLVD	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Cancer Research Manpower	000	2	6/9/2025	NON-COMPETING CONTINUATION	$248,509
														Subtotal = $248,509

Issue Date FY: 2024 ( Subtotal = $248,509 )
2024	2024	CHILDREN'S HOSPITAL OF PHILADELPHIA, THE	3401 CIVIC CENTER BLVD	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Cancer Research Manpower	000	1	1/10/2024	NEW	$248,509
														Subtotal = $248,509

Grand Total All Awards = $497,018

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Calming the Cytokine Storm: Unraveling the Biology of CRS and ICANS

Award Number: K08CA286762

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer